DDX11-AS1 As Potential Therapy Targets for Human Hepatocellular Carcinoma
Overview
Authors
Affiliations
Hepatocellular Carcinoma (HCC) is one of the most fatal cancers, whose incidence and death rates are still rising. Here, we report the identification of long non-coding RNAs (IncRNAs) that associated with HCC progression and metabolism based on the systematically analysis of large scale RNA-seq data from HCC patients. We identified seven lncRNAs with high confidence which were highly related with prognostic of HCC. Of note, three of them had quite different expression patterns between the control samples and the patients, and their critical roles in cancer progression were validated. We proposed that DDX11-AS1 play important role during HCC oncogenesis and may serve as potential therapy target for HCC.
Nanostructure-assisted drought tolerance in olive trees ( L.): the role of FeO-graphitic carbon.
Gholami R, Fahadi Hoveizeh N, Zahedi S, Padervand M, Dawi E, Carillo P Front Plant Sci. 2024; 15:1454619.
PMID: 39297012 PMC: 11408303. DOI: 10.3389/fpls.2024.1454619.
LncRNAs-associated to genomic instability: A barrier to cancer therapy effectiveness.
Andonegui-Elguera M, Caceres-Gutierrez R, Oliva-Rico D, Diaz-Chavez J, Herrera L Front Genet. 2022; 13:984329.
PMID: 36479250 PMC: 9719945. DOI: 10.3389/fgene.2022.984329.
Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma.
Wang F, Lin H, Su Q, Li C World J Surg Oncol. 2022; 20(1):275.
PMID: 36050740 PMC: 9434888. DOI: 10.1186/s12957-022-02727-7.
Unveiling a Ghost Proteome in the Glioblastoma Non-Coding RNAs.
Cardon T, Fournier I, Salzet M Front Cell Dev Biol. 2022; 9:703583.
PMID: 35004666 PMC: 8733697. DOI: 10.3389/fcell.2021.703583.
Wu C, Wang Z, Tian X, Wang J, Zhang Y, Wu B Bioengineered. 2021; 12(1):3772-3786.
PMID: 34281459 PMC: 8806645. DOI: 10.1080/21655979.2021.1940617.